<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Commenti a: Wound Care Plus, LLC Adopts the MolecuLight i:X® as a Standard Point-of-Care Device for its Wound Care Service Offering to the Long-Term Care and Extended Care Markets 	</title>
	<atom:link href="https://www.newpharmaitaly.it/wound-care-plus-llc-adopts-the-moleculight-ix-as-a-standard-point-of-care-device-for-its-wound-care-service-offering-to-the-long-term-care-and-extended-care-markets/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.newpharmaitaly.it/wound-care-plus-llc-adopts-the-moleculight-ix-as-a-standard-point-of-care-device-for-its-wound-care-service-offering-to-the-long-term-care-and-extended-care-markets/</link>
	<description>Il portale delle news in ambito farmaceutico</description>
	<lastBuildDate>Thu, 10 Dec 2020 10:01:28 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>
</channel>
</rss>
